sur NanoViricides, Inc. (NASDAQ:NNVC)
NanoViricides President to Present at PODD Conference
On October 22, 2024, NanoViricides, Inc. announced that Dr. Anil R. Diwan, the company's President, will present at the PODD Conference. The conference takes place on October 28-29, 2024, at the Westin Boston Seaport District. Dr. Diwan's presentation, scheduled for October 28, focuses on nanomedicines that revolutionize antiviral treatments.
The discussion will highlight the NV-387 drug candidate, which has shown promise against respiratory viruses with excellent safety in Phase 1 clinical trials. NV-387 demonstrated effectiveness in animal models against various viruses including RSV and Influenza A/H3N2. The NanoViricides platform aims to refine drug delivery, offering oral availability and enhanced drug protection against metabolism.
By addressing issues like solubility and bioavailability, the platform seeks to advance drug candidates often excluded from development due to unfavorable PKPD characteristics. NanoViricides envisions further development for treatments like COVID-19 and other viral infections leveraging this technology.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NanoViricides, Inc.